Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company lowered its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 82.0% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 97,161 shares of the company's stock after selling 442,928 shares during the quarter. The Manufacturers Life Insurance Company owned approximately 0.08% of Henry Schein worth $6,724,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the stock. Olstein Capital Management L.P. grew its stake in Henry Schein by 17.2% in the fourth quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company's stock valued at $7,543,000 after purchasing an additional 16,000 shares during the last quarter. Private Management Group Inc. lifted its position in Henry Schein by 5.7% during the fourth quarter. Private Management Group Inc. now owns 350,515 shares of the company's stock valued at $24,256,000 after acquiring an additional 18,882 shares during the last quarter. Equitable Trust Co. acquired a new stake in Henry Schein in the fourth quarter valued at approximately $417,000. Savant Capital LLC grew its holdings in Henry Schein by 43.9% in the fourth quarter. Savant Capital LLC now owns 4,651 shares of the company's stock worth $322,000 after purchasing an additional 1,420 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. increased its position in shares of Henry Schein by 29.9% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 15,854 shares of the company's stock worth $1,113,000 after purchasing an additional 3,650 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company's stock.

Henry Schein Stock Performance

NASDAQ HSIC traded up $1.29 during mid-day trading on Monday, reaching $69.93. 144,466 shares of the stock were exchanged, compared to its average volume of 1,630,677. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The business's 50 day moving average is $67.59 and its 200-day moving average is $71.46. The company has a market capitalization of $8.57 billion, a P/E ratio of 28.67, a P/E/G ratio of 2.13 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, beating analysts' consensus estimates of $1.11 by $0.04. The firm had revenue of $3.17 billion for the quarter, compared to analysts' expectations of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company's quarterly revenue was down .1% on a year-over-year basis. During the same period last year, the firm earned $1.10 EPS. On average, equities research analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have weighed in on HSIC. Piper Sandler lowered their price target on Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a report on Wednesday, April 30th. Jefferies Financial Group raised their price target on shares of Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a report on Thursday, January 23rd. UBS Group dropped their price objective on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a report on Wednesday, February 26th. StockNews.com cut Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. Finally, Wells Fargo & Company decreased their price objective on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 6th. Six research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $79.30.

Insider Transactions at Henry Schein

In other news, Director Philip A. Laskawy sold 2,604 shares of Henry Schein stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the sale, the director now owns 24,805 shares in the company, valued at $1,762,147.20. This trade represents a 9.50% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Bradford C. Connett sold 4,036 shares of the company's stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the transaction, the chief executive officer now owns 62,688 shares of the company's stock, valued at approximately $4,460,251.20. This trade represents a 6.05% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.08% of the company's stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.